Search results
BioAtla, Inc. (NASDAQ:BCAB) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance UK· 8 months agoBioAtla, Inc. (NASDAQ:BCAB) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Good...
Q3 2023 GlycoMimetics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance UK· 8 months agoParticipants Christian Dinneen-Long; General Counsel; GlycoMimetics, Inc. Harout Semerijian; CEO; GlycoMimetics, Inc. Edwin Rock; CFO; GlycoMimetics, Inc. Brian Hahn; Chief Medical Officer; ...
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance UK· 8 months agoTrevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2023 Earnings Call Transcript November 12, 2023 Operator:...
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance UK· 3 months agoCellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript March 27, 2024 Cellectar...
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance UK· 4 months agoCardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2023 Earnings Call Transcript February 29, 2024 Cardiff...
Marinus (MRNS) Up 20% on Financial and Pipeline Updates
Zacks via Yahoo Finance UK· 10 months agoMarinus' (MRNS) shares rise as it provides revenue and cash guidance for third-quarter 2023. The...
Biomea Fusion (BMEA) Stock Surges 41% in a Month: Here's Why
Zacks via Yahoo Finance UK· 7 months agoBiomea Fusion (BMEA) rises 41% in a month on the back of positive investor expectations regarding...
Q1 2024 Trevi Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance UK· 2 months agoParticipants Jennifer Good; President, Chief Executive Officer, Director; Trevi Therapeutics Inc Lisa Delfini; Chief Financial Officer; Trevi Therapeutics Inc David Clark; Chief Medical Officer ...
Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
Zacks via Yahoo Finance UK· 3 months agoInterim results from a late-stage study show that Marinus' (MRNS) ganaxolone failed to meet the...
